Keyphrases
Endometrial Adenocarcinoma
100%
Human Leukocyte antigen-G (HLA-G)
100%
G Protein
45%
Protein Staining
27%
Disease Stage
18%
RNA Fluorescence in Situ Hybridization (RNA-FISH)
18%
Immunohistochemical Staining
18%
Metastatic Disease
18%
Glandular Epithelium
18%
Clinical Markers
18%
Tumor Histology
18%
Epithelium
9%
Monoclonal Antibody
9%
Immune Regulation
9%
Receiver Operating Characteristic Curve
9%
Endometrial Cancer
9%
Regulatory Proteins
9%
Carcinoma
9%
Spearman Rank Correlation
9%
Tumor Stage
9%
Tumor Grade
9%
Receiver Operating Characteristic Analysis
9%
Advanced Stage Disease
9%
Anti-human Leukocyte Antigen
9%
Tumor Disease
9%
Preoperative Prediction
9%
Metastatic Endometrial Cancer
9%
Medicine and Dentistry
Human Leukocyte Antigen
100%
Endometrium Carcinoma
100%
Guanine Nucleotide Binding Protein
45%
Diseases
27%
Metastatic Carcinoma
18%
Uterine Cancer
18%
In Situ Hybridization
18%
Neoplasm
9%
Monoclonal Antibody
9%
Carcinoma
9%
Regulator Protein
9%
Implant
9%
Tumor Histology
9%
Cancer Stages
9%
Agricultural and Biological Sciences
Leukocyte
100%
G Protein
45%
In Situ Hybridization
18%
Neoplasm
18%
Tumor
18%
Malignant Neoplasm
18%
Monoclonal Antibody
9%
Regulatory Protein
9%